Martindale Pharma® Announces New Long Term Supply Agreement with Burton Hospitals NHS Foundation Trust
WOOBURN GREEN, England, May 31, 2016 /PRNewswire/ --
Strategic and Trusted Supplier of Essential Medicines to the NHS
Martindale Pharma, the UK based leading international specialty pharma company today announced it has signed a multi-year exclusive manufacturing agreement with Burton Hospitals NHS Foundation Trust. Under the terms of the agreement, Burton Hospitals NHS Foundation Trust will supply a number of Martindale Pharma's key specialty generic products including Bismuth Iodoform Paraffin Paste (BIPP) and Lidocaine and Phenylephrine Topical Solution, both routine treatments in Ear Nose and Throat (ENT) surgery. Financial terms were not disclosed.
Michael Clark, Chief Marketing Officer, commented: "This news follows two years of collaborative work with the Burton Hospital, one of our best performing contract manufacturing partners. We believe this new agreement demonstrates how pharmaceutical companies can support NHS manufacturing units and offer patients the best drugs currently available on the market."
Martindale Pharma is recognised as a strategic partner to the NHS, having maintained a close partnership with NHS manufacturing units over the years, as well as supporting NHS staff with first-class training. For the past six years, Martindale Pharma has worked with the UCL School of Pharmacy and London North West Healthcare NHS Trust's Q3P Qualified Person (QP) Training Course providing academic and practical training to NHS Qualified Person trainees: as part of the course the pharmaceutical packaging module is hosted annually at Martindale Pharma's Romford facility.
Michael Clark added "We are very pleased to be able to share our expertise and knowledge in the manufacturing industry with trainee QPs and NHS Manufacturing units. Our expertise, combined with our modern, upgraded UK manufacturing facility not only allows us to manufacture high quality medicines efficiently, but supply these to a wide range of countries and health care systems, notably the UK where we have over 100 different products on contract to supply the UK NHS."
About Martindale Pharma®
Martindale Pharma is a leading UK-based, international specialty pharmaceutical company providing essential medicines to over 28 countries around the world.
Our strategy is to build leading positions in defined business segments where there is a high unmet medical need and a demand for improved product presentations. Our focus is on Opioid Addiction, Emergency Care, Hospital-initiated Medicines, Ophthalmics and Unlicensed Medicines (also called "Specials").
With a strong UK presence with expertise in marketing hospital and specialty medicines, Martindale Pharma is recognised as a strategic partner to the NHS and other healthcare providers and supplying over 100 licensed products and with a track record of successful new specialty product launches.
The business also includes a rapidly growing international organisation currently centred on three geographical regions: Saudi Arabia and the Gulf Co-Operation Council territory, Australia and South East Asia and Northern Europe (focused on Scandinavia).
Uniquely as an independent pharma company the company is underpinned by our own modern, efficient UK manufacturing facility which enables us to develop and compete globally to supply high quality, low cost specialty pharmaceuticals in sterile injection and oral liquid formats.
For further information visit our new website www.martindalepharma.co.uk
Share this article